How Fast Does GLP-1 Work? Week-by-Week Timeline

Quick Answer

GLP-1 medications begin reducing appetite within the first 1–2 weeks. Measurable weight loss typically appears on the scale by weeks 2–4. Most patients lose 5–10% of body weight by month 3. Maximum results (15–21% body weight) occur at 12–18 months of continued treatment. The process is gradual — not rapid.

Week-by-Week Timeline

Week 1–2: Appetite Changes Begin

The most immediate effect is appetite suppression, not weight loss. Within days of the first dose:

Reduced hunger between meals
Earlier satiety (feeling full on less food)
Decreased interest in highly palatable/processed foods
Possible onset of mild nausea

The first dose is low (0.25 mg semaglutide or 2.5 mg tirzepatide) — specifically designed to minimize side effects during the adjustment period. At this starting dose, some patients feel minimal effects; the therapeutic appetite suppression increases with each dose escalation.

Week 2–4: First Weight Loss Appears

Most patients begin seeing scale movement during this window. Typical early losses: 2–6 lbs in the first month.

Some of this early weight reflects water weight and glycogen depletion from eating less — not all fat. This is normal.

Month 2–3 (Week 5–12): Meaningful Progress

By month 3, most patients have:

Lost 5–10% of starting body weight
Escalated to a higher dose (often the second or third step on the titration schedule)
Adjusted to GI side effects (which typically improve significantly by this point)

The STEP 1 trial data shows semaglutide users lose approximately 5.5–7% of body weight by week 12.

Month 4–6: Continued Steady Loss

Weight loss continues at a rate of 1–3 lbs per month for most patients. This is slower than the initial phase but represents true fat loss at a sustainable rate.

The titration continues — semaglutide users who are tolerating well move toward the maintenance dose (2.4 mg) during this period. Tirzepatide users progress toward higher doses (7.5–10 mg and above).

Month 6–12: Approaching Maximum Loss

Weight loss rate typically slows as patients approach their biological plateau — the point where the body equilibrates at the new lower weight despite continued medication.

At 6 months:

Average semaglutide: ~10–12% body weight loss
Average tirzepatide: ~14–16% body weight loss

Month 12–18: Maximum Results

Clinical trials measured primary endpoints at 68–72 weeks (approximately 16–18 months). This is where maximum published weight loss outcomes occur:

Semaglutide at maintenance: ~14.9% body weight loss
Tirzepatide at maintenance: ~20.9% body weight loss

Why Results Take This Long

GLP-1 works by creating a sustained caloric deficit through appetite suppression — not by directly burning fat or blocking absorption. The rate of weight loss is limited by the size of the caloric deficit and the body's rate of fat mobilization.

The slow titration schedule (dose increases every 4 weeks) also means full therapeutic effect builds gradually. You're not at your maximum dose until month 4–5 of treatment.

What Affects How Fast It Works

Body weight: Heavier patients may lose more absolute pounds in early months (larger caloric deficit) but percentage loss is similar.

Dosing compliance: Missing doses slows progress. Consistent weekly injection timing matters.

Diet quality: The medication suppresses appetite; dietary choices determine whether the remaining calories come from protein (muscle-preserving) or refined carbohydrates.

Starting dose and titration: Some providers use faster titration schedules for patients with excellent tolerability; this can accelerate results slightly.

Insulin resistance: Patients with significant insulin resistance or type 2 diabetes may see slightly slower early response; blood sugar normalization happens alongside fat loss.

What "Working" Looks Like Month by Month

Month	Expected Weight Loss	What's Happening
1	2–6 lbs (1–3%)	Appetite suppression begins; water weight/glycogen
2–3	5–10% total	Steady fat loss; GI adjustment complete
4–6	8–14% total	Approaching maintenance dose; continuing loss
9–12	12–18% total	Near maximum effect; plateau beginning
15–18	15–21% total	Maximum clinical trial results

Start Your GLP-1 Treatment and Track Your Progress

Bottom Line

GLP-1 medications begin working on appetite within days, produce measurable weight loss within weeks, and reach maximum effect at 12–18 months. The process is slower than many patients expect — this isn't a medication that produces dramatic results in 30 days. Consistency through the dose escalation period is critical; most patients who stick with the titration schedule and maintain it for a year achieve results that are clinically meaningful and not achievable with diet alone.